5.62
전일 마감가:
$5.88
열려 있는:
$5.88
하루 거래량:
79,897
Relative Volume:
0.76
시가총액:
$66.24M
수익:
$52.29M
순이익/손실:
$-73.52M
주가수익비율:
-8.5152
EPS:
-0.66
순현금흐름:
$-100.45M
1주 성능:
+3.31%
1개월 성능:
+12.18%
6개월 성능:
+32.86%
1년 성능:
-37.28%
Precision Biosciences Inc Stock (DTIL) Company Profile
명칭
Precision Biosciences Inc
전화
919-314-5512
주소
302 EAST PETTIGREW STREET, DURHAM, NC
DTIL을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
DTIL
Precision Biosciences Inc
|
5.62 | 69.31M | 52.29M | -73.52M | -100.45M | -0.66 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
![]()
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
![]()
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
Precision Biosciences Inc Stock (DTIL) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2025-01-10 | 업그레이드 | BMO Capital Markets | Market Perform → Outperform |
2024-04-30 | 개시 | Guggenheim | Buy |
2022-06-17 | 개시 | BMO Capital Markets | Outperform |
2022-06-09 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
2020-07-27 | 재개 | BTIG Research | Buy |
2020-04-03 | 다운그레이드 | Goldman | Buy → Neutral |
2020-03-05 | 개시 | Stifel | Buy |
2020-02-25 | 개시 | William Blair | Outperform |
2019-08-09 | 개시 | BTIG Research | Buy |
2019-07-16 | 개시 | H.C. Wainwright | Buy |
2019-04-22 | 개시 | Barclays | Overweight |
2019-04-22 | 개시 | Goldman | Buy |
2019-04-22 | 개시 | JP Morgan | Overweight |
2019-04-22 | 개시 | Jefferies | Buy |
모두보기
Precision Biosciences Inc 주식(DTIL)의 최신 뉴스
Is Precision BioSciences Inc. meeting your algorithmic filter criteriaQuarterly Growth Report & Community Driven Trade Alerts - newser.com
What high frequency data says about Precision BioSciences Inc.July 2025 Opening Moves & High Conviction Buy Zone Alerts - newser.com
Key metrics from Precision BioSciences Inc.’s quarterly dataWeekly Volume Report & Short-Term High Return Strategies - newser.com
Will Precision BioSciences Inc. stock gain from lower inflationPortfolio Value Report & Fast Moving Stock Trade Plans - newser.com
News impact scoring models applied to Precision BioSciences Inc.IPO Watch & Free Technical Pattern Based Buy Signals - newser.com
Using RSI to spot recovery in Precision BioSciences Inc.Market Movement Recap & AI Forecasted Entry and Exit Points - newser.com
Will Precision BioSciences Inc. stock recover faster than marketTrade Ideas & Weekly Hot Stock Watchlists - newser.com
What moving averages say about Precision BioSciences Inc.July 2025 Fed Impact & Expert Approved Momentum Trade Ideas - newser.com
Precision BioSciences Forms Golden Cross, Signaling Potential Bullish Breakout - Markets Mojo
Precision BioSciences Announces Publication in Nucleic Acids Research Elucidating the Mechanisms for - PharmiWeb.com
Precision BioSciences (DTIL) Showcases Genomic Advances with ARCUS Technology - GuruFocus
Relative strength of Precision BioSciences Inc. in sector analysisWall Street Watch & Community Verified Swing Trade Signals - newser.com
Precision BioSciences Announces Publication in Nucleic Acids Research Elucidating the Mechanisms for High Efficiency Gene Insertion in Dividing and Non-Dividing Cells Using ARCUS Nucleases - The AI Journal
Best data tools to analyze Precision BioSciences Inc. stockMarket Risk Analysis & Weekly High Potential Alerts - newser.com
Regression analysis insights on Precision BioSciences Inc. performanceJuly 2025 Macro Moves & High Return Trade Opportunity Guides - newser.com
Does Precision BioSciences Inc. qualify in momentum factor screeningWeekly Trade Review & Risk Managed Investment Entry Signals - newser.com
Is Precision BioSciences Inc. (PBS0) stock a top dividend aristocrat candidateJuly 2025 Movers & Safe Entry Point Identification - newser.com
Why retail investors pile into Precision BioSciences Inc. stock2025 Market Overview & Reliable Volume Spike Alerts - newser.com
Precision BioSciences Announces Opening of First Clinical Trial Site in U.S. for ELIMINATE-B Trial - BioSpace
Precision Biosciences, Inc. Announces Opening of First Clinical Trial Site in U.S. for Eliminate-B Trial - MarketScreener
Precision BioSciences (DTIL) Commences U.S. Clinical Trial for P - GuruFocus
Automated trading signals detected on Precision BioSciences Inc.July 2025 Trends & Safe Entry Zone Tips - newser.com
Can Precision BioSciences Inc. (PBS0) stock hold up in economic slowdownPortfolio Risk Report & Reliable Price Action Trade Plans - newser.com
What momentum indicators show for Precision BioSciences Inc. stockOptions Play & Verified Swing Trading Watchlist - newser.com
Order flow analysis tools used on Precision BioSciences Inc.Weekly Gains Report & Fast Exit Strategy with Risk Control - newser.com
Can a trend reversal in Precision BioSciences Inc. lead to recoveryWeekly Investment Summary & Fast Exit and Entry Strategy Plans - newser.com
Why Precision BioSciences Inc. stock is rated strong buyTrade Risk Assessment & Precise Entry and Exit Recommendations - newser.com
Published on: 2025-10-05 04:45:59 - newser.com
Why Precision BioSciences Inc. stock attracts high net worth investorsTrade Risk Summary & Free High Return Stock Watch Alerts - newser.com
Why global investors buy Precision BioSciences Inc. (PBS0) stock2025 Fundamental Recap & Safe Investment Capital Preservation Plans - newser.com
Published on: 2025-10-03 06:51:55 - newser.com
How to integrate Precision BioSciences Inc. into portfolio analysis toolsQuarterly Risk Review & Daily Price Action Insights - newser.com
Is Precision BioSciences Inc. (PBS0) stock undervalued by metricsJuly 2025 Trends & High Conviction Trade Alerts - newser.com
Is Precision BioSciences Inc. building a consolidation baseMarket Growth Summary & High Accuracy Trade Signal Alerts - newser.com
Precision Biosciences Inc (DTIL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Precision Biosciences Inc 주식 (DTIL) 내부자 거래
내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
---|---|---|---|---|---|---|---|
Brown Melinda | Director |
Sep 22 '25 |
Buy |
4.89 |
1,400 |
6,846 |
21,965 |
Kelly John Alexander | Chief Financial Officer |
Jul 03 '25 |
Sale |
4.26 |
14,827 |
63,163 |
73,485 |
자본화:
|
볼륨(24시간):